Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001367644-22-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-25 | 2022-02-23+ | EBS | Kramer Robert | Pres, CEO, Dir | F - Tax | $42.37 | -3,453 | 159.3K | -2% | -$146.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | F | D | 1,419 | $42.23 | 161,303 | D | — | — | (F1) Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. |
| 2 | Common | Common Stock | 2022-02-24 | F | D | 2,034 | $42.47 | 159,269 | D | — | — | (F1) Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. |